CHV II, L.P. 4
4 · Phreesia, Inc. · Filed Jul 24, 2019
Insider Transaction Report
Form 4
CHV II, L.P.
10% Owner
Transactions
- Conversion
Senior B Preferred Stock
2019-07-22−1,139,530→ 0 total(indirect: By CHV II, L.P.)→ Common Stock (492,424 underlying) - Conversion
Common Stock
2019-07-22+1,934,225→ 1,934,225 total(indirect: By CHV II, L.P.) - Conversion
Common Stock
2019-07-22+492,424→ 2,945,249 total(indirect: By CHV II, L.P.) - Conversion
Senior A Preferred Stock
2019-07-22−1,082,016→ 0 total(indirect: By CHV II, L.P.)→ Common Stock (518,600 underlying) - Conversion
Common Stock
2019-07-22+518,600→ 2,452,825 total(indirect: By CHV II, L.P.) - Sale
Common Stock
2019-07-22$18.00/sh+335,767$6,043,806→ 2,609,482 total(indirect: By CHV II, L.P.) - Conversion
Junior Convertible Preferred Stock
2019-07-22−4,250,111→ 0 total(indirect: By CHV II, L.P.)→ Common Stock (1,934,225 underlying)
Footnotes (4)
- [F1]Upon the closing of the Issuer's initial public offering, all shares of Junior Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Junior Convertible Preferred Stock had no expiration date.
- [F2]Shares held directly by CHV II, L.P. Ascension Health Ventures II, LLC dba Ascension Ventures II, LLC is the general partner of CHV II, L.P. Each of these entities expressly disclaims beneficial ownership of the shares listed above except to the extent of any pecuniary interest therein.
- [F3]Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date.
- [F4]Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.